EPITHET: Positive result after reanalysis using baseline diffusion-weighted imaging/perfusion-weighted imaging co-registration

Stroke

Volumn 42, Issue 1, 2011, Pages 59-64

  Nagakane, Yoshinari ^a   Christensen, Soren ^a   Brekenfeld, Caspar ^a,b   Ma, Henry ^a   Churilov, Leonid ^a   Parsons, Mark W ^c   Levi, Christopher R ^c   Butcher, Kenneth S ^d   Peeters, Andre ^e   Barber, P Alan ^f   Bladin, Christopher F ^g   De Silva, Deidre A ^a,h   Fink, John ⁱ   Kimber, Thomas E ^j   Schultz, David W ^k   Muir, Keith W ^l   Tress, Brian M ^a   Desmond, Patricia M ^a   Davis, Stephen M ^a   Donnan, Geoffrey A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d UNIVERSITY OF ALBERTA   (Canada)

^e CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^f AUCKLAND CITY HOSPITAL   (New Zealand)

^g Eastern Melbourne Neurosciences   (Australia)

^h NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

ⁱ CHRISTCHURCH HOSPITAL   (New Zealand)

^j ROYAL ADELAIDE HOSPITAL   (Australia)

^k FLINDERS MEDICAL CENTRE   (Australia)

^l UNIVERSITY OF GLASGOW   (United Kingdom)

more..

Author keywords

Magnetic resonance imaging; Mismatch; Penumbra; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; PLACEBO;

ADULT; AGED; ARTICLE; BRAIN INFARCTION SIZE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISMATCH NEGATIVITY; NEUROIMAGING; OUTCOME ASSESSMENT; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; REGISTRATION; REPERFUSION; STROKE; VOLUMETRY;

AGED; AGED, 80 AND OVER; BRAIN INFARCTION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 79451474059     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.580464     Document Type: Article

References (11)

1. Donnan GA, Baron JC, Davis SM, Sharp FR. The Ischemic Penumbra. New York: Informa Healthcare; 2007.
2. Baird AE, Benfield A, Schlaug G, Siewert B, Lövblad KO, Edelman RR, Warach S. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol. 1997;41:581-589. (Pubitemid 27212651)
3. Donnan GA, Davis SM. Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy. Lancet Neurol. 2002;1: 417-425.
4. Darby DG, Barber PA, Gerraty RP, Desmond PM, Yang Q, Parsons M, Li T, Tress BM, Davis SM. Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke. 1999;30:2043-2052.
5. Harris AD, Kosior RK, Chen HS, Andersen LB, Frayne R. Evolution of hyperacute stroke over 6 hours using serial MR perfusion and diffusion maps. J Magn Reson Imaging. 2009;29:1262-1270.
6. Olivot JM, Mlynash M, Thijs VN, Purushotham A, Kemp S, Lansberg MG, Wechsler L, Bammer R, Marks MP, Albers GW. Relationships between cerebral perfusion and reversibility of acute diffusion lesions in DEFUSE: insights from RADAR. Stroke. 2009;40:1692-1697.
7. Ma H, Zavala JA, Teoh H, Churilov L, Gunawan M, Ly J, Wright P, Phan T, Arakawa S, Davis SM, Donnan GA. Penumbral mismatch is underestimated using standard volumetric methods and this is exacerbated with time. J Neurol Neurosurg Psychiatry. 2009;80:991-996.
8. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM, EPITHET investigators. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008; 7:299-309.
9. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G, SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275-282.
10. Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, Gerraty RP, Tress BM, Wright PM, Donnan GA, Davis SM. Diffusionand perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol. 2002;51:28-37.
11. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP, DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60:508-517.